Viewing Study NCT06760702


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2025-12-26 @ 2:59 AM
Study NCT ID: NCT06760702
Status: RECRUITING
Last Update Posted: 2025-01-07
First Post: 2024-11-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients with Colorectal, Ovarian, and Renal Cancers
Sponsor: Aurigene Discovery Technologies Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module